Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion type Assertion NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_head.
- NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion description "[This study was designed in accordance with the hypothesis that polymorphisms (-37 and -524) of the RRM1 promoter gene sequence, which regulate RRM1 expression, could influence the efficacy and prognosis of lung cancer patients treated with gemcitabine-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_provenance.
- NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion evidence source_evidence_literature NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_provenance.
- NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion SIO_000772 18483375 NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_provenance.
- NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion wasDerivedFrom gad-20150221 NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_provenance.
- NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_assertion wasGeneratedBy ECO_0000203 NP80201.RAlkxtl3XccS0VlGHempKTBaLrh-F2XrPcQfgM3IECNNQ130_provenance.